Patents Assigned to Minerva Imaging APS
  • 177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII
    Publication number: 20230146930
    Abstract: There is provided a 177-Lu labelled peptide for site-specific targeting of TF thereby enabling treatment of a cancer disease associated with high TF expression; e.g. treatment of cancer by administering to a patient an effective amount of the 177-Lu labelled peptide.
    Type: Application
    Filed: June 30, 2022
    Publication date: May 11, 2023
    Applicant: Minerva Imaging APS
    Inventors: Andreas KJAER, Carsten HAAGEN NIELSEN